Evidence map›Paper›PMID 32109231›Full record

ArticleNature communications2020

A comparative genomics methodology reveals a widespread family of membrane-disrupting T6SS effectors.

Chaya M Fridman, Kinga Keppel, Motti Gerlic, Eran Bosis, Dor Salomon

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
11.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 106 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. TseCurrent research in microbial sciences · 2026
    Article
  10. The multifunctional type VI secretion system ofApplied and environmental microbiology · 2025
    Review
  11. An electron transport complex required in the gut sensitizesProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  12. Article
  13. A nonenzymatic effector disruptsProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Chaya M FridmanDepartment of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, 6997801, Israel.
Kinga KeppelDepartment of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, 6997801, Israel.
Motti GerlicDepartment of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, 6997801, Israel.ORCID http://orcid.org/0000-0001-9518-1833
Eran BosisDepartment of Biotechnology Engineering, ORT Braude College of Engineering, Karmiel, 2161002, Israel. bosis@braude.ac.il.ORCID http://orcid.org/0000-0001-7762-5920
Dor SalomonDepartment of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, 6997801, Israel. dorsalomon@mail.tau.ac.il.ORCID http://orcid.org/0000-0002-2009-9453
Tel Aviv University · ILBraude College of Engineering Karmiel · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gram-negative bacteria deliver effectors via the type VI secretion system (T6SS) to outcompete their rivals. Each bacterial strain carries a different arsenal of effectors; the identities of many remain unknown. Here, we present an approach to identify T6SS effectors encoded in bacterial genomes of interest, without prior knowledge of the effectors' domain content or genetic neighborhood. Our pipeline comprises a comparative genomics analysis followed by screening using a surrogate T6SS

Indexed as

Anti-Bacterial AgentsBacterial Outer MembraneBacterial ProteinsBacterial ToxinsDrug DiscoveryGenome, BacterialGenomicsPeriplasmType VI Secretion SystemsVibrio parahaemolyticusAnti-Bacterial AgentsBacterial ProteinsBacterial ToxinsType VI Secretion Systems

Identifiers

PMID32109231
PMCPMC7046647
OpenAlexW3009389754

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.